MEDICINAL COMPLEX FOR TREATING TYPE 2 DIABETES AND DIABETIC DYSLIPIDEMIA

• Main Authors: PARK, Ki Sook, JUNG, Jong Hyuk, KIM, Ji Yoon, YOON, Hye Jin, KIM, Sung Won, KIM, Ri Sun, AHN, Jae Soon, YOO, Seok Cheol
• Format: Patent
• Language: English; French; Korean
• Published: 24.05.2018
• Subjects: HUMAN NECESSITIES; HYGIENE; MEDICAL OR VETERINARY SCIENCE; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES

The present invention relates to a medicinal complex for effectively treating type 2 diabetes and dyslipidemia of diabetic patients, more specifically, the present invention provides a medicinal complex comprising a peptidase IV inhibitor gemigliptin or a pharmaceutically acceptable salt thereof, and a HMG-CoA reductase inhibitor rosuvastatin or a pharmaceutically acceptable salt thereof, to effectively control blood sugar levels and improve cardiovascular disease risk factors. La présente invention concerne un complexe médicinal destiné à traiter efficacement le diabète de type 2 et la dyslipidémie de patients diabétiques; plus spécifiquement, la présente invention concerne un complexe médicinal comprenant la gémigliptine - un inhibiteur de la peptidase IV, ou un sel pharmaceutiquement acceptable de ce composé, et la rosuvastatine - un inhibiteur de la HMG-CoA réductase, ou un sel pharmaceutiquement acceptable de ce composé, qui permet de réguler efficacement les taux de glycémie et d'améliorer les facteurs de risque de maladies cardio-vasculaires. 본 발명은 제2형 당뇨병 및 당뇨 환자의 이상지질혈증을 효율적으로 치료하기 위한 복합제제에 관한 것으로, 보다 상세하게는 펩티다아제 IV 억제제인 제미글립틴 또는 이의 약제학적으로 허용가능한 염 및 HMG-CoA 환원효소 억제제인 로수바스타틴 또는 이의 약제학적으로 허용가능한 염을 포함하는 복합제제를 제공함으로써 효율적으로 혈당조절 및 심혈관계 질환 위험인자 개선을 하기 위한 것에 관한 것이다.